Literature DB >> 6304684

Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes.

F Bontemps, G Van den Berghe, H G Hers.   

Abstract

The effect of adenosine on the metabolism of prelabeled adenine nucleotides was investigated in isolated hepatocytes. Adenosine caused an approximately equal to 2-fold increase in the ATP content of the cells. This effect was in part counteracted by an increased rate of adenine nucleotide catabolism that could be explained by a stimulation of both AMP deaminase (AMP aminohydrolase, EC 3.5.4.6) and the cytoplasmic 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) because of the increased concentration of ATP. The unexpected finding that labeled adenosine was formed immediately after the addition of the unlabeled nucleoside could be explained by the trapping effect of adenosine. An accumulation of labeled adenosine was observed also in the presence of 5-iodotubercidin, a potent inhibitor of adenosine kinase (ATP:adenosine 5'-phosphotransferase, EC 2.7.1.20). Under these conditions, there was a decrease in the concentration of ATP in the cell and a 2- to 3-fold increase in the rate of formation of allantoin. This formation of adenosine was only slightly decreased by inhibition of the membranous 5'-nucleotidase; it led to the accumulation of S-adenosylhomocysteine in the presence of coformycin and an excess of L-homocysteine. It was concluded that, under basal conditions, the cytoplasmic 5'-nucleotidase present in the liver cell continuously produces adenosine, which is immediately reconverted into AMP by adenosine kinase, without giving rise to allantoin. This futile cycle between AMP and adenosine amounts to at least 20 nmol/min per g of liver and, thus, exceeds the basic rate of allantoin formation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304684      PMCID: PMC393925          DOI: 10.1073/pnas.80.10.2829

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The dependence of glucose formation from lactate on the adenosine triphosphate content in the isolated perfused rat liver.

Authors:  J Wilkening; J Nowack; K Decker
Journal:  Biochim Biophys Acta       Date:  1975-06-12

2.  The "adenosine cycle" is not a significant route of purine metabolism im mammalian cells.

Authors:  L W Brox; J F Henderson
Journal:  Can J Biochem       Date:  1976-02

3.  Alternative pathways of deoxyadenosine and adenosine metabolism.

Authors:  F F Snyder; J F Henderson
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

4.  Preparation and properties of 5'-nucleotidase from smooth muscle of small intestine.

Authors:  R M Burger; J M Lowenstein
Journal:  J Biol Chem       Date:  1970-12-10       Impact factor: 5.157

5.  Adenosine formation and metabolism during adenosine triphosphate catabolism in Ehrlich ascites tumor cells.

Authors:  C A Lomax; J F Henderson
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

6.  Purine excretion by mammalian cells deficient in adenosine kinase.

Authors:  T S Chan; K Ishii; C Long; H Green
Journal:  J Cell Physiol       Date:  1973-06       Impact factor: 6.384

7.  Inhibitors of nucleoside and nucleotide metabolism.

Authors:  J F Henderson; A R Paterson; I C Caldwell; B Paul; M C Chan; K F Lau
Journal:  Cancer Chemother Rep 2       Date:  1972-11

8.  In vivo modification of the energy charge in the liver cell.

Authors:  V Chagoya de Sánchez; A Brunner; E Piña
Journal:  Biochem Biophys Res Commun       Date:  1972-02-16       Impact factor: 3.575

9.  Mode of inhibition of coformycin on adenosine deaminase.

Authors:  T Sawa; Y Fukagawa; I Homma; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1967-07       Impact factor: 2.649

10.  Effect of adenosine on the adenine nucleotide content and metabolism of hepatocytes.

Authors:  P Lund; N W Cornell; H A Krebs
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

View more
  35 in total

1.  The rate of the AMP/adenosine substrate cycle in concanavalin-A-stimulated rat lymphocytes.

Authors:  Z Szondy; E A Newsholme
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

2.  Adenosine dysfunction and adenosine kinase in epileptogenesis.

Authors:  Detlev Boison
Journal:  Open Neurosci J       Date:  2010-01-01

3.  The mechanism by which adenosine decreases gluconeogenesis from lactate in isolated rat hepatocytes.

Authors:  A Lavoinne; H A Buc; S Claeyssens; M Pinosa; F Matray
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

4.  Intense exercise induces the degradation of adenine nucleotide and purine nucleotide synthesis via de novo pathway in the rat liver.

Authors:  Toshio Mikami; Jun Kitagawa
Journal:  Eur J Appl Physiol       Date:  2005-12-21       Impact factor: 3.078

5.  5-nucleotidase activity in cultured cell lines. Effect of different assay conditions and correlation with cell proliferation.

Authors:  J Turnay; N Olmo; G Risse; K von der Mark; M A Lizarbe
Journal:  In Vitro Cell Dev Biol       Date:  1989-11

6.  The role of adenosine kinase in regulating adenosine concentration.

Authors:  A C Newby
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

7.  Adenine nucleotide metabolism in isolated chicken hepatocytes.

Authors:  J Spychała; G Van den Berghe
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

8.  The pathogenesis of the Lesch-Nyhan syndrome: ATP use is positively related to hypoxanthine supply to hypoxanthine guanine phosphoribosyltransferase.

Authors:  R A Harkness; G M McCreanor; R Greenwood
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

9.  Hepatocyte heterogeneity in response to extracellular adenosine.

Authors:  Y Morimoto; M Wettstein; D Häussinger
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

Review 10.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.